Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study

PHASE2RecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

September 18, 2024

Primary Completion Date

March 31, 2028

Study Completion Date

December 31, 2028

Conditions
WheezingAsthma in Children
Interventions
DRUG

Soy isoflavone

Soy isoflavone supplement (Novasoy) that contains isoflavones (genistein, daidzein, glycetein) given at a dose of genistein aglycone equivalents to provide the genistein dosing of 22.6 mg/day for children aged 2-10 months, and 30.3 mg/day children aged 10-24 months

DRUG

matching placebo

A matching placebo also administered twice daily.

Trial Locations (2)

60611

RECRUITING

Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago

RECRUITING

Northwestern University Feinberg School of Medicine, Chicago

All Listed Sponsors
collaborator

Northwestern University

OTHER

collaborator

University of South Florida

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Rajesh Kumar

OTHER